Related Experiment Video
Updated: Jun 20, 2026
10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Mining administrative and clinical diabetes data with temporal association rules.
Stefano Concaro1, Lucia Sacchi, Carlo Cerra
1Dipartimento di Informatica e Sistemistica, Università di Pavia, 27100 Pavia, Italy. stefano.concaro@unipv.it
Studies in Health Technology and Informatics
|September 12, 2009
Summary
Analyzing integrated healthcare data from Pavia
Area of Science:
- Health Informatics
- Data Analysis
- Public Health
Background:
- The Regional Healthcare Agency (ASL) of Pavia manages a comprehensive database of administrative and clinical health data.
- Integrated health data analysis offers potential for assessing healthcare delivery processes.
Purpose of the Study:
- To apply an algorithm for extracting Temporal Association Rules from hybrid event sequences.
- To evaluate the care delivery flow for Diabetes Mellitus using integrated data.
Main Methods:
- Utilized an algorithm for Temporal Association Rule extraction.
- Analyzed sequences of hybrid administrative and clinical healthcare events.
- Focused on the care delivery pathway for Diabetes Mellitus.
Main Results:
- Demonstrated the application of Temporal Association Rule extraction on integrated healthcare data.
- Showcased the method's ability to leverage diverse healthcare information sources.
- Provided a framework for evaluating care delivery pertinence for specific pathologies.
Conclusions:
- The developed method effectively analyzes integrated healthcare data to assess care delivery.
- This approach can identify and refine inappropriate practices leading to suboptimal health outcomes.
- The findings support evidence-based adjustments to healthcare delivery for improved patient outcomes.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:18Introduction To Survival Analysis
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
The primary goal of survival analysis is to estimate survival time—the time until a...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...